Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts 02129, USA.
J Infect Dis. 2010 Oct 15;202 Suppl 2(Suppl 2):S309-14. doi: 10.1086/655653.
The extensive genetic diversity of human immunodeficiency virus type 1 (HIV-1) presents a significant barrier to the development of an effective and durable HIV vaccine. This variability not only makes it difficult to identify the targets against which immune responses should be directed, but it also confers on the virus the capacity for rapid escape from effective immune responses. Here, we describe recent investigations of the genetic diversity of HIV-1 at transmission and of the evolution of the virus as it adapts to the host immune environment during the acute phase of HIV-1 infection. These studies increase our understanding of the virology of the earliest stages of HIV-1 infection and provide critical insights into the mechanisms underlying viral replication and immune control of diverse HIV-1 strains. Such knowledge will inform the design of smarter, more effective vaccines capable of inducing immune control of HIV-1.
人类免疫缺陷病毒 1 型(HIV-1)的广泛遗传多样性对有效和持久的 HIV 疫苗的开发构成了重大障碍。这种变异性不仅使得确定免疫反应应该针对的目标变得困难,而且还使病毒具有从有效免疫反应中迅速逃逸的能力。在这里,我们描述了 HIV-1 在传播过程中的遗传多样性以及病毒在 HIV-1 感染急性期适应宿主免疫环境时的进化的最新研究。这些研究增加了我们对 HIV-1 感染早期阶段病毒学的理解,并为病毒复制和对不同 HIV-1 株的免疫控制的机制提供了重要的见解。这些知识将为设计更智能、更有效的疫苗提供信息,这些疫苗能够诱导对 HIV-1 的免疫控制。